| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.68B | +1.2% |
| Cost of Revenue | $1.36B | +3.2% |
| Gross Profit | $326.0M | -6.6% |
| R&D Expense | $29.0M | +5.4% |
| SG&A Expense | $145.6M | -7.8% |
| Operating Income | $47.2M | -65.4% |
| Pre-tax Income | $14.9M | -86.2% |
| Income Tax | $9.0M | -25.7% |
| Net Income | $5.9M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $16.7M | +25.7% |
| Accounts Receivable | $193.8M | +0.5% |
| Inventory | $441.3M | -0.1% |
| Current Assets | $724.2M | +2.1% |
| Total Assets | $1.70B | -3.7% |
| Current Liabilities | $226.7M | -11.1% |
| Long-term Debt | $443.9M | +3.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $87.8M | -39.2% |
| Capital Expenditures | $68.6M | -37.9% |
| Investing Cash Flow | -$79.6M | +33.2% |
| Financing Cash Flow | -$4.2M | +83.2% |
| Free Cash Flow | $19.2M | -43.4% |
| -93.8% |
| EPS (Basic) | $0.28 | -94.0% |
| EPS (Diluted) | $0.28 | -93.9% |
| Stockholders' Equity |
| $868.9M |
| -1.8% |